Caption Management, LLC Solid Biosciences Inc. Transaction History

Caption Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.49 - $5.51 $61,075 - $96,425	-17,500 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$5.37 - $10.72 $93,975 - $187,600	17,500 New	17,500 $98,000
Q3 2019 Nov 14, 2019	SELL	$4.33 - $11.64 $75,775 - $203,700	-17,500 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$4.6 - $10.13 $96,599 - $212,730	-21,000 Reduced 54.55%	17,500 $100,000
Q1 2019 May 14, 2019	BUY	$7.19 - $32.37 $276,815 - $1.25 Million	38,500 New	38,500 $354,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $24.6M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.